Investor Relations

PHILAB Holdings Corp., formerly Alterra Capital Partners Inc., is the holding company of one of the pioneer Philippine companies focused on life science equipment and services.  Hector Thomas Navasero acquired 67% of Alterra Capital Partners in August 2016 which in turn acquired 93% of PHILAB Industries in December 2016.  Today Philab Holdings is the new name of Alterra Capital Partners Inc. and its shares are traded on the Philippine Stock Exchange with the ticker symbol DNA.

PHILAB Industries Inc. has a leading position in supplying life science equipment to the healthcare, pharmaceutical, semiconductor and food/beverage industries which it built over the past 58 years. It has designed and built numerous school and advanced research laboratories as well as providing science teaching tools. Its presence in In Vitro Diagnostics today comes in the form of the LABit series of portable self-test kits for Dengue and several infectious diseases.

On the second week of January 2017, a Registration Statement and Listing Application for a Follow On Offering were submitted to the SEC and PSE respectively.

Connect with us through our email, investorrelations@philab.com.

Follow on Offering

Quick Facts

Company:
PHILAB Holdings, Corp.

Stock Symbol on the PSE:
DNA

Current stock price:
6.42 Php (as of May 10, 2017)

Market Capital:
14.7 B

For more stock info about our company, visit our page on the PSE website.

Keep up-to-date with the latest business and financial info straight from our IR team by joining the PHILAB Investor Relations group.